SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC Keeping it real board for pro and con discussions
NNVC 1.220-3.2%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NewMoney_812 who wrote (26)12/19/2014 10:25:26 AM
From: drkaz  Read Replies (2) of 326
 
You already know the answer to that question.

Definition of Drug Pipeline:
moneyterms.co.uk

"In the pharmaceuticals sector, a drugs pipeline consists of the drugs that a company has under development or is testing. This includes completely new drugs, variants of existing drugs and new applications of existing drugs. The pipeline starts with new drug discoveries and it is important to assess companies' ability to discover new drugs as well as drugs that are currently in the pipeline. The early stage of the pipeline needs to be refilled as drugs move up. Good R & D is crucial. "

Flucide IV
Flucide Oral
Ebolacide
MERScide
Denguecide,....

All qualify as part of the 'drug pipeline' for NNVC. A couple of others I haven't listed that are less far along also qualify as part of the 'pipeline'. Just because none of the drugs has reached the end of the 'pipeline' doesn't mean that the 'pipeline' does not exist, and that drugs are moving through it.

Don't pretend to be that dumb - we both know that you are smarter than that.

Sufficient enlightenment? Or should I continue?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext